ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,482.80
-0.34%
S&P ASX All Technology
3,992.90
-1.03%
Brent Oil
75.755
1.52%
US Dollar vs AUD
1.59269
-0.14%
Bitcoin
97,335.48
0.88%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Gelteq Ltd (GELS) Share Price

Gelteq Ltd

Gelteq Ltd (GELS)

NASDAQ
2.14
-0.15
( -6.55% )
Updated: 04:04:58
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
2.14
Bid
2.14
Offer
2.25
Volume
13,264
2.14 Day's Range 2.2659
1.42 52 Week Range 5.50
Previous Close
2.29
Open
2.26
Last Trade
374
@
2.14
Last Trade Time
04:07:42
Average Volume (3m)
548,023
Financial Volume
US$ 29,052
VWAP
2.1903

Ask ADVFN Intelligence (AI)

GELS Latest News

More News

Gelteq Launches SportsGel Brand and Signs Distribution Agreement with E-Commerce Solutions Company in Asia-Pacific Region, WPIC

NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and...

05 February 2025
GlobeNewswire Inc.

Gelteq Appoints Matthew Jones as Head of Sports Performance

NEW YORK, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and...

25 January 2025
GlobeNewswire Inc.

Gelteq Appoints Dr. Paul Wynne as Chief Scientific Officer to Propel Innovative Ingestible Gel Technology

NEW YORK, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and...

20 December 2024
GlobeNewswire Inc.

Gelteq Receives FDA Approval of its Suitability Petition for New Animal Drug

NEW YORK, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and biotechnology company focused on developing and commercializing white label...

18 December 2024
GlobeNewswire Inc.

Gelteq to Participate in the Benchmark Company 13th Annual Discovery Investor Conference

NEW YORK, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company that is focused on developing and commercializing...

10 December 2024
GlobeNewswire Inc.

Gelteq Announces Largest U.S. Customer Increases Initial Order by 50% to Meet Growing Market Demand

NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company that is focused on developing and commercializing...

03 December 2024
GlobeNewswire Inc.

Gelteq Announces 400,000 Units Enter into Production in November 2024

NEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company focused on developing and commercializing white label...

27 November 2024
GlobeNewswire Inc.

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

16 November 2024
Edgar (US Regulatory)

Gelteq Expands Operations in United States with Appointment of Adam Bendell as President of U.S. Operations to Scale Domestic Business

NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company that is focused on developing and commercializing...

13 November 2024
GlobeNewswire Inc.

Form NT 20-F - Notification of inability to timely file Form 20-F

01 November 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.05-2.283105022832.192.46212.1406542.22567785CS
4-0.26-10.83333333332.42.841.874634442.61756282CS
120.3922.28571428571.755.51.425480233.40973417CS
26-1.86-46.545.51.424502903.37931743CS
52-1.86-46.545.51.424502903.37931743CS
156-1.86-46.545.51.424502903.37931743CS
260-1.86-46.545.51.424502903.37931743CS

GELS - Frequently Asked Questions (FAQ)

What is the current Gelteq share price?
The current share price of Gelteq is US$ 2.14
What is the 1 year trading range for Gelteq share price?
Gelteq has traded in the range of US$ 1.42 to US$ 5.50 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CYNCYNGN Inc
US$ 0.14395
(139.12%)
1.04B
BNAIBrand Engagement Network Inc
US$ 0.701
(70.98%)
199.98M
MGOLMGO Global Inc
US$ 0.691
(66.51%)
444.31M
BDRXBiodexa Pharmaceuticals PLC
US$ 6.43
(57.99%)
19.66M
PNBKPatriot National Bancorp Inc
US$ 2.1791
(50.28%)
51.07M
PLRXPliant Therapeutics Inc
US$ 3.18
(-59.18%)
12.4M
SMTCSemtech Corp
US$ 37.99
(-30.31%)
11.45M
GSIWGarden Stage Ltd
US$ 0.5584
(-29.15%)
3.4M
LTRYLottery com Inc
US$ 1.165
(-27.19%)
5.52M
MYNAMynaric AG
US$ 0.288162
(-25.02%)
878.67k
CYNCYNGN Inc
US$ 0.1443
(139.70%)
1.04B
MGOLMGO Global Inc
US$ 0.6928
(66.94%)
444.49M
OCEAOcean Biomedical Inc
US$ 0.1451
(9.18%)
404.84M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0715
(32.41%)
201.79M
BNAIBrand Engagement Network Inc
US$ 0.7004
(70.83%)
199.99M

Discussion

View Full Feed
hondaboost hondaboost 2 minutes ago
FNVWF, $0.05. It'll go to dollars with $1 Billion Reverse Merger with an EV truck company coming soon!

FNVWF, $0.05, filing for $1 Billion Reverse Merger :

https://www.otcmarkets.com/filing/html?id=18092314&guid=2_0-kee5FMdqJth

With just 4.3 M O/S, it'll
Jack_Bolander Jack_Bolander 2 minutes ago
https://www.hydrogeninsight.com/transport/high-costs-are-not-the-only-challenges-facing-hydrogen-fuel-cell-vehicles-the-technology-itself-has-issues-study/2-1-1774143
PLUG
Redoocs Redoocs 2 minutes ago
Just curious on how much your bags weigh being a bagholder yourself.

GO DBMM!
DBMM
stealofadeal stealofadeal 2 minutes ago
$GEVI Exciting future for this company. Mighty Fire Breaker and the fire retardant solution CitroTech. Good stuff!
https://youtu.be/8zUDxez4s4s?si=epr6pXeE5YjR6WCW
GEVI
Frankestin Frankestin 2 minutes ago
Seth get your balls out and do buy back now! 🙏
If you know they won't delist you, do it!
TNXP
getmoreshares getmoreshares 3 minutes ago
nobody buying or selling- todays dollar vol Volume $ 2,565- everyone must be too busy POSTING
NBRI
ORCA ORCA 3 minutes ago
I ADDED ANOTHER 100K TODAY AT .0176.AND GOT A TON ON THE BIDS WAITING.THE STOCK UNDER ACCUMULATION.
THE SHARES ARE GETTING TIGHT.
GMER
PatB1 PatB1 3 minutes ago
It reads like the anatomy of a  very poorly run company. They are in the death throws now and no way to recover. Unfortunate, with all the great research they have. But this is a dead company right! This will be a lot of investors tax write off for 2025!
RSPI
ToddM ToddM 3 minutes ago
So up the A/S or go ahead and R/S?? What will shady RONN do? 
RONN
SonicCitadel16 SonicCitadel16 3 minutes ago
Did message you
RONN
Semper Fi 88 Semper Fi 88 3 minutes ago
Trend Analysis
FNMA appears to be correcting within a longer-term bullish trend. Although its MACD is presently below the signal line, shares remain 212.6% above an upwards sloping 200-day moving average. Comparative Relative Strength analysis shows that this issue is outperforming the S&P 50
FNMA
SecondLife SecondLife 3 minutes ago
https://forbiddennews.substack.com/p/federal-documents-prove-obama-ordered?utm_source=post-email-title&publication_id=1658626&post_id=156759497&utm_campaign=email-post-title&isFreemail=true&r=x33x&triedRedirect=true&utm_medium=email
Acme Investments Acme Investments 4 minutes ago
That's why I never get excited about one day of good volume!! Still think we've hit bottom though!!
AFFU
SecondLife SecondLife 4 minutes ago
https://forbiddennews.substack.com/p/federal-documents-prove-obama-ordered?utm_source=post-email-title&publication_id=1658626&post_id=156759497&utm_campaign=email-post-title&isFreemail=true&r=x33x&triedRedirect=true&utm_medium=email
Zorax Zorax 4 minutes ago
shitface always turns it around to him right? Eagles announced this weeks ago.
Trooperstocks Trooperstocks 4 minutes ago
$ACGX .10 +26.18% on news! ($ACGX) Reports Successful Sale of Chicago Real Estate Property with Significant Financial Gains to the Company; New Investments Now Being Sought #OTCMarkets #ACGX https://www.einpresswire.com/article/784083279/alliance-creative-group-acgx-reports-sale-of-chicago-property-
ACGX
Trooperstocks Trooperstocks 4 minutes ago
$ACGX .10 +26.18% on news! ($ACGX) Reports Successful Sale of Chicago Real Estate Property with Significant Financial Gains to the Company; New Investments Now Being Sought #OTCMarkets #ACGX https://www.einpresswire.com/article/784083279/alliance-creative-group-acgx-reports-sale-of-chicago-property-
ACGX
Stock_Barber Stock_Barber 5 minutes ago
True... but it depends on what is coming!
LEEN
BigJuan BigJuan 5 minutes ago
$OCEA bouncing off new lows with solid news out. Can it squeeze here with continued volume??

" style="caret-color: rgb(51, 51, 51); color: rgba(51, 51, 51, 1); font-family: lato, sans-serif; font-size: 22px"Ocean Biomedical Announces Breakthrough Findings in EGFR-Mutant Lung Cancer an
OCEA
getmoreshares getmoreshares 5 minutes ago
https://www.otcmarkets.com/filing/html?id=18169570&guid=PS0-keTzDwZnJth
GEGP
BigJuan BigJuan 5 minutes ago
$OCEA bouncing off new lows with solid news out. Can it squeeze here with continued volume??

" style="caret-color: rgb(51, 51, 51); color: rgba(51, 51, 51, 1); font-family: lato, sans-serif; font-size: 22px"Ocean Biomedical Announces Breakthrough Findings in EGFR-Mutant Lung Cancer an
OCEA
th6565 th6565 5 minutes ago
I think we met on LWLG message board sometime ago, I am out there now but still watching it closely.

I came here 2/3 years ago, never think myself a pumper. I was trying to show through NIOBW I could gain much more if NB succeeds.

Bought some NB and POET lately, keep t
LWLG
jimmybob jimmybob 6 minutes ago
The Morning Rant ->

https://www.youtube.com/watch?v=DSVBL7gwCyQ

🎬0:15 $SPY $SPX $DIA #deepseek #tariffs #powell #CPI #ppi
🎬4:15 $ROKU #roku
🎬5:25 $TDOC #teladoc
🎬6:35 $TRIP #tripadvisor
🎬7:15 $A
ANET DIA LMND

Your Recent History

NASDAQ
GELS
Gelteq
BOV
S1PL34
Splunk
AMEX
SMOG
VanEck Low Carbon Energy...
BIT
P1EYT3
BNP Paribas Issuance
BIT
S28951
Societe Generale Effekten
BIT
UC7F5A
Unicredit Bank
BIT
F21372
Vontobel Financial Produ...
USOTC
AHOTF
American Hotel Income Pr... (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads